Clinical characteristics, management, and outcomes of cadmium poisoning: a systematic review of case reports and case series

Objective: This paper synthesizes case reports and series to outline the clinical features, diagnosis, treatment, and prognosis of cadmium poisoning. It offers structured evidence to improve understanding, early diagnosis, and clinical management, aiding healthcare professionals in prevention and intervention.

Methods: The study protocol has been registered in the PROSOPERO system (CRD420251128280). We independently searched PubMed, Scopus, and Cochrane databases using keywords including “cadmium poisoning,” “case report,” and “case series.” Only English-language case reports and series with confirmed or highly suspected cadmium poisoning were included, up to May 2025. Animal studies, reviews, and articles lacking individual patient data were excluded. Additional references were identified from the bibliographies of retrieved articles. Study quality was assessed using the JBI tool for case reports/series.

Results: Among the 12 included studies, there were a total of 17 patients. We found that cadmium poisoning primarily affects adult males and is often associated with occupational exposure. Common risk factors include smoking and alcohol consumption. The study also found that low iron stores exacerbate cadmium poisoning. Diagnosis relies on a combination of clinical diagnostic tests, blood and urine tests, chest X-rays, kidney ultrasounds, bone density measurements, and skeletal imaging. The treatment plan includes the use of chelating agents to reduce cadmium levels in the body and antibiotics to maintain the patient’s condition. For patients with concurrent lung and kidney involvement, mechanical ventilation and continuous renal replacement therapy (CRRT) may be required. Additionally, for patients with osteochondropathy, supplementation with calcium and vitamin D is recommended. While most patients have a favorable prognosis, fatal cases due to respiratory failure or renal failure have been reported.

Conclusion: This review emphasizes that cadmium poisoning is rare and complex, with non- specific symptoms and a tendency to cause organ damage. Therefore, it is necessary to enhance clinical vigilance. Occupational exposure highlights the need for public health surveillance. Diagnosis relies on blood or urine cadmium testing, which is crucial for guiding treatment. Although the condition is relatively uncommon and most patients have a favorable prognosis, the risk of severe complications and mortality underscores the importance of timely and individualized treatment. Further research is needed to optimize management and improve long-term outcomes.

Systematic review registration: (registration number: CRD420251128280).

Introduction

Exposure to cadmium (Cd poisoning) is relatively rare but potentially life-threatening. The incidence is significantly higher in populations exposed to welding or industrial work involving cadmium, making it a growing concern for both public health and occupational safety. Although rare, the risk of developing complications and death increases significantly with inappropriate or delayed treatment. For instance, a study of 7,131 cadmium workers, conducted in the United Kingdom, reported 1,105 deaths (1). In a study of biochemical analysis in a population with high cadmium exposure, 5 out of 27 copper smiths exposed to cadmium fumes (18.5%) had kidney stones. Compared to the control, they showed evidence of kidney damage through blood biochemistry and proteinuria (2). In a study of amino aciduria among Japanese workers in the cadmium industry, amino aciduria was elevated to varying degrees, with differing impacts on kidney function (3). Research indicates that cadmium not only harms occupational populations but also has a significant impact on local populations in areas with high cadmium concentrations. A study in the Yatağán coal mining region of Turkey demonstrated that cadmium also affects metal levels in local children (4). Early detection and management are essential to prevent adverse outcomes. Studies have explored several mechanisms that increase the risk of cadmium accumulation in the body. For instance, smoking can potentially increase cadmium absorption in the lungs, indirectly leading to increased cadmium load in the body (5). Alcohol intake can also increase the gastrointestinal absorption of cadmium (6). In addition, iron deficiency is a risk factor for increased blood and urine cadmium (7).

Clinically, cadmium poisoning can manifest a variety of symptoms, some of which are atypical, often leading to delays in diagnosis and treatment, which may result in worsening of the condition. Common symptoms include cough, respiratory distress, and fever. In addition, it also presents with diarrhea, joint pain, and elevated urea and creatinine levels (8, 9).

The diagnosis of cadmium poisoning relies heavily on the physician’s clinical assessment and routine biochemical tests. However, the atypical symptoms of cadmium poisoning also increase the difficulty of diagnosis. Therefore, biochemical examinations are particularly important. Measuring cadmium concentration in blood and urine helps determine the severity of cadmium poisoning.

Cadmium poisoning is primarily treated using chelating agents that help to remove cadmium ions from the body; however, the safety and effectiveness of this treatment option remain controversial (9, 10). Since cadmium poisoning has a similar clinical presentation to pneumonia, doctors might initially administer treatment for pneumonia if cadmium exposure is not known, missing a critical treatment window, leading to a poorer prognosis (11).

This systematic review integrates evidence from published case reports and case series studies of patients diagnosed with cadmium poisoning to comprehensively describe their clinical characteristics and diagnostic strategies, summarize management approaches including chelation therapy and supportive care, and report on patient outcomes, including recovery, mortality, and sequelae. This review provides a structured overview, offering clinicians and public health professionals a structured summary of evidence to enhance awareness of cadmium poisoning, promote early diagnosis and timely intervention, and provide guidance for clinical management and preventive measures.

Methods

Protocol and registration

This systematic review follows the reporting guidelines for systematic reviews and meta-analyses and involves a secondary analysis of published studies (12). The study protocol has been registered in the PROSOPERO system (registration number: CRD420251128280).

Literature search

We developed our search strategy in consultation with a subject specialist to ensure completeness and relevance. The strategy used a combination of Medical Subject Headings (MeSH) terms and free-text keywords, incorporating terms such as “cadmium poisoning,” “case report,” and “case series.” The databases searched were PubMed, Scopus, and Cochrane, covering publications up to May 2025. The search was limited to articles published in English. Reference lists of relevant articles and reviews were also screened to identify additional studies.

Research quality assessment

We used the JBI checklist to assess the quality of the included case reports. The JBI checklist was originally described by Munn et al., and it provides a structured framework for assessing the risk of bias and reporting adequacy in case-based evidence.¹ By applying this tool, we ensured that the evidence included in this review was critically appraised in a standardized and transparent manner.

Study selection

The retrieved studies were imported into EndNote 20.0 (Clarivate Analytics, Philadelphia, United States) for duplicate removal and screening. Two independent researchers screened study titles and abstracts, followed by a full-text review of potentially eligible studies based on the inclusion and exclusion criteria. Any discrepancies were resolved through discussion, with adjudication by a third researcher when necessary.

Inclusion and exclusion criteria

The inclusion criteria for this overview were as follows: (1) the study population consisted of patients with cadmium poisoning; (2) the study was either a case report or a case series.

Articles were excluded if: (1) The study population was not the target population, (2) non-target interventions were performed on the target population. (3) Methodological flaws in the study (inadequate diagnosis, abnormal termination of treatment follow-up), or (4) Missing data: Data on core variables (such as exposure levels and primary outcome measures) are missing from the study and cannot be obtained by contacting the authors. (5) Contradictory results: The results of clinical diagnosis and treatment contradict the theoretical expected results.

Data extraction

Data extracted from each study included:

Study characteristics: author(s), year of publication, and country of study.

• Patient demographics: age, gender, adverse lifestyle habits and occupation.

• Clinical manifestations: signs and symptoms at the time of consultation.

• Diagnostic methods: clinical diagnostic tests and biochemical tests, etc.

• Treatment modalities: conventional treatment of cadmium poisoning, pulmonary ventilation, renal replacement therapy (CRRT).

• Outcomes: clinical outcomes (recovery and relapse), complications, sequelae, mortality, and duration of follow-up.

Two independent reviewers extracted data using a standardized form. Discrepancies were resolved through discussion or consultation with a third reviewer.

Statistical analysis

We used Microsoft Excel (Microsoft Corp, Seattle, WA, United States) for data collection and organization. Furthermore, we used descriptive statistics to summarize the raw data, presenting the means and standard deviations for continuous variables, while frequencies and percentages were reported for categorical variables.

Results

Literature search

A total of 253 documents were retrieved using the specified search terms “cadmium poisoning,” “case series,” and “case report.” After excluding 96 duplicate documents, 157 documents were included in the full-text review. Among these, 145documents were further excluded due to reasons such as the study subjects not being the target population, inconsistent outcome measures, and missing data. Ultimately, 12 documents met the inclusion criteria and were included in the systematic review. The detailed screening process is shown in Figure 1.

Figure 1

Figure 1. Flowchart of literature screening.

Research quality assessment

We conducted a comprehensive assessment of the 12 included documents. After independent evaluation, all 12 studies met the inclusion criteria, and their methodological quality was considered reliable. The detailed appraisal outcomes are presented in Table 1. It should be noted that this review is based solely on 12 case reports/case series, with a limited sample size, which to some extent limits the representativeness and generalizability of the results.

Table 1

Table 1. Conduct a JBI checklist review of the case reports.

Demographic characteristics

The 12 included articles reported a total of 17 cases of cadmium poisoning. Among these cases, patients ranged from 23 to 78 years of age. Most cases occurred in the 30 to 50 years age group and were predominantly male, which aligns with the typical age and gender distribution of welders and metalworkers. Occupational exposure is the primary cause of cadmium poisoning. The vast majority of patients with cadmium poisoning usually have an occupational history of exposure to cadmium. However, poor lifestyle habits are important factors that contribute to poor prognosis in cadmium poisoning. Prolonged smoking can increase urinary cadmium concentrations and the risk of long-term complications. Men who smoke and drink alcohol are also at higher risk of developing complications. In addition, low iron stores in the body enhance cadmium absorption. Case report information and patient demographic characteristics are shown in Table 2.

Table 2

Table 2. The demographic characteristics of the cases.

Diagnosis

The most common diagnostic method for cadmium poisoning is laboratory examination. Although respiratory symptoms are often prominent, clinical diagnosis alone is insufficient, as these symptoms are not easily distinguished from those in pneumonia, which can lead to misdiagnosis. Therefore, laboratory tests play a crucial role. Measuring blood and urine cadmium concentrations provides key evidence for confirming cadmium poisoning. In more severe cases, chest x-ray examination and renal ultrasonography are needed to determine organ abnormalities (7). For cases with nonspecific findings, bone density measurements and bone imaging are also needed to determine bone abnormalities (9, 13). For detailed information, please refer to Table 3.

Table 3

Table 3. The clinical symptoms and diagnostic methods of the cases.

Complications in cadmium poisoning

Complications in cadmium poisoning are multifaceted and involve several body organs and tissues. The most common complications involve the lungs and kidneys. Inhalation of high concentrations of cadmium fumes can damage capillaries and lead to acute cadmium pneumonia (14). Chronic low-dose cadmium exposure may result in chronic obstructive pulmonary disease (COPD) with pulmonary fibrosis (15). In the kidneys, cadmium toxicity primarily causes tubular damage by disrupting cellular homeostasis, which can progress to tubular necrosis (16). Cadmium poisoning can also affect other systems, including the skeletal, cardiovascular, and digestive systems, among others. The typical skeletal system disorders identified in the study include achalasia and osteoporosis (6). Cadmium-induced cardiovascular diseases are generally acute and most commonly occur following exposure to high concentrations (17). Gastrointestinal diseases may develop when inhaled cadmium irritates the mucosa of the gastrointestinal tract, causing congestion, edema, and necrosis (8). Table 3 summarizes the clinical manifestations and diagnostic methods used for patients in detail.

Treatment

Treatment of cadmium poisoning depends on the severity of the condition. The primary goal is to reduce the body cadmium concentration, and there are several options suitable for different clinical situations. Table 4 summarizes the treatment methods included in the case reports. For mild cadmium poisoning, disengagement from exposure may reduce cadmium concentrations in the body. For instance, in the case report involving a 28-year-old female jewelry worker, the patient’s blood cadmium level decreased from 26 μg/L to 1 μg/L (near the normal range of < 5 μg/L) within 6 months after disengagement, consistent with cadmium’s blood half-life (rapid clearance period of 2–3 months). Additionally, her urinary β₂-microglobulin dropped from 0.16 mg/L to 0.07 mg/L, suggesting a partial reversal of renal tubular injury (18).

Table 4

Table 4. The treatment methods and prognosis of the case.

In cases of cadmium poisoning with high cadmium concentrations, clinical management typically categorizes such cases into acute poisoning and chronic poisoning. In acute poisoning, supportive therapy and chelation therapy are commonly used to manage multi-organ dysfunction. However, chelating agents such as ethylenediaminetetraacetic acid (EDTA) while effective in reducing blood cadmium levels, also carry side effects that can cause varying degrees of damage to human organs. Given the significant adverse effects, the widespread use of such agents remains a matter of consideration. Additionally, clinical trials must demonstrate that their clinical benefits can produce favorable outcomes for all cadmium poisoning patients. Therefore, strict monitoring of the patient’s condition and a cautious risk–benefit assessment are required prior to use.

In order to mitigate the negative effects associated with chelation therapy, it is recommended to use other agents in combination during treatment to reduce its negative effects, and to investigate whether other alternative therapies can be more effective.

For chronic cadmium poisoning,traditional Chinese medicine is effective in lowering cadmium concentrations. In severe cases, Chinese medicines (e.g., Si-Yi Tang to improve shock), combined with rehabilitation exercises (Baduan Jin), may help to promote recovery (17). For patients with respiratory symptoms, oxygen therapy and pulmonary ventilation are needed to maintain normal respiratory function. Renal replacement therapy (CRRT) may be required for those with acute kidney injury or abnormal renal function. Electrolytes and acid–base disturbances should be corrected with appropriate supplementation.

Currently, the clinical treatment of cadmium poisoning faces numerous challenges. First, there are very few reported cases of cadmium poisoning. Second, the clinical symptoms exhibited by cadmium poisoning patients are scattered, so the results are only for reference and cannot be used as high-level evidence. In addition, the long-term efficacy of treatment is still unclear, and cadmium poisoning is easily confused with diseases such as lung cancer and metal fever, all of which increase the difficulty of treating cadmium poisoning.

Outcome and follow-up

The outcome and follow-up of cadmium poisoning vary depending on the severity of the condition and treatment provided. Timely and appropriate treatment often leads to a good prognosis. For patients with acute poisoning, removal from exposure and supportive therapy can lead to a good prognosis. However, serious complications such as multiple organ failure (MODS), renal edema, and damage to the renal cortex can occur, leading to high mortality (17). In patients with chronic poisoning, renal injury is common and may progress to Fanconi syndrome during follow-up.

In some cases, the outcome is fatal, usually due to unrecognized cadmium poisoning. Cadmium poisoning can be misdiagnosed as pneumonia-related illness or metal fume fever. Table 4 provides a comprehensive summary of the prognosis of patients.

Discussion

This review provides a comprehensive overview of cadmium poisoning. In terms of gender distribution, males were predominant among the reported cases; however, this does not mean that males are more susceptible to cadmium poisoning. In the 12 case reports, a higher proportion of males were engaged in occupations such as welding and metalworking. Therefore, it is hypothesized that cadmium poisoning is highly correlated with occupational exposure rather than gender.

Several key factors may exacerbate the symptoms of cadmium poisoning. Poor lifestyle habits, such as smoking and alcohol intake, are important aggravating factors. Smoking and alcohol consumption are known to worsen the symptoms of cadmium poisoning and significantly increase the risk of severe cases (19). A study showed that smoking increased the risk of microalbuminuria by 5.147 times (95% CI, 2.568–10.314, p < 0.001), and people who drink alcohol had a higher prevalence of microalbuminuria compared to non-drinkers (44.4% vs. 27.0%, p = 0.003). The increased incidence of proteinuria suggests a higher likelihood of nephropathy (20). In addition, low iron storage in the body can lead to increased absorption of cadmium from the intestinal tract, resulting in higher blood and urine cadmium concentrations and a greater overall body burden (21). Animal studies have also shown that alcohol intake increases urinary cadmium excretion in cadmium-exposed mice compared to non-drinking controls (22).

Diagnosis of cadmium poisoning is particularly challenging because symptoms such as shortness of breath, cough, and chest pain closely resemble those of common pneumonia and other respiratory illnesses. In the case report mentioned above, a patient with cadmium poisoning was misdiagnosed as having chemical metal fume fever, which led to a missed opportunity for optimal treatment (11). Therefore, biochemical testing is essential for identifying cadmium poisoning, as elevated levels of cadmium in blood and urine can confirm the diagnosis.

Patient-specific symptoms such as osteomalacia and elevated urinary protein require close attention. In one case report, a patient had elevated levels of FGF-23, which is associated with the development of osteomalacia. The presence of proteinuria indicated renal tubular dysfunction (9, 13). These findings reflect the pathological damage of organs linked to cadmium poisoning, i.e., the development of complications. Therefore, during follow-up and subsequent evaluations, it is also important to monitor changes in the patient’s physical condition and observe the emergence of complications and sequelae. In fatal cases, autopsy provides a definitive diagnosis of cadmium poisoning. Autopsy results indicate that death in cadmium poisoning is due to lesions in the lungs, kidneys, and other organs (23).

The treatment of cadmium poisoning involves reducing the cadmium concentrations in various organs of the body by using chelating agents. This involves using EDTA (calcium sodium ethylenediaminetetraacetic acid), which forms a complex with the cadmium ions, to promote the elimination of the ions. However, EDTA has been reported to be toxic to the kidneys. Studies have shown that EDTA increases urinary cadmium excretion, but does not affect cadmium bound to metallothionein (MT; mainly stored in the liver and kidney). However, it may lead to a sudden increase in cadmium concentration in the proximal tubule of the kidney by forming complexes with cadmium in the blood, exacerbating renal injury. EDTA has a dual effect: in acute experiments, EDTA increased urinary cadmium excretion (+35%). On the other hand, renal cortical cadmium concentration increased by 22% because the Cd-EDTA complex was actively reabsorbed by the renal tubules (via the OAT1 transporter) (10). During acute cadmium poisoning, the amount of cadmium ingested is relatively small (compared to the amount ingested in chronic kidney cadmium damage), and chelation therapy can rapidly reduce cadmium levels in the body, thereby mitigating the harm caused by heavy metals to the human body. This explains why EDTA therapy holds a priority position in the treatment of acute cadmium poisoning. However, the cadmium-EDTA complex is excreted through the kidneys via urine, and the kidneys release a small amount of cadmium. Therefore, this method requires monitoring of renal function (10). Furthermore, it has a limited effect on chronic accumulation (24). Animal studies have also found that EDTA may exacerbate tubular injury, which limits its clinical use (25).

In addition to nephrotoxicity, cadmium ion levels may also affect calcium ion balance in the body. In an animal experiment, a single intravenous injection of cadmium chloride was administered to animals at doses of 0.01, 0.015, and 0.02 millimoles per kilogram of body weight. Six hours later, serum calcium levels decreased by 2 to 4 milligrams per 100 milliliters. In surviving animals, levels remained low after 24 h. Additionally, an epidemiological study found an association between cadmium levels and cardiovascular disease. In a Korean epidemiological study, an increase in the interquartile range (IQR) of blood cadmium levels (0.91 micrograms/liter) was associated with an increased risk of IHD [OR 2.1, 95% confidence interval (CI) 1.3–3.4] (26).

In addition to the aforementioned negative clinical effects of EDTA, its efficacy remains questionable. In a large-scale randomized clinical trial (TACT2) conducted in the United States and Canada, 959 patients with a history of myocardial infarction and diabetes were enrolled to compare the effects of EDTA chelation therapy versus placebo on cardiovascular events. The results showed that the chelation group experienced a significant reduction in blood lead levels, but there was no significant difference between the chelation group and the placebo group in terms of the primary endpoint, cardiovascular mortality, and all-cause mortality. This clinical trial confirmed that EDTA has no actual benefits, further deepening clinical doubts about the feasibility of EDTA therapy.

Although EDTA therapy has a certain effect in treating heavy metal poisoning, there is considerable controversy over its clinical feasibility and potential negative effects, and whether it can be used to treat other diseases. For non-poisoning-related uses, such as coronary artery disease, this treatment method has not yet been approved by the FDA (27).

In response to the limitations of EDTA in the treatment of cadmium poisoning, some scholars have proposed the combined use of glutathione to prevent renal toxicity. In an experiment evaluating the efficacy and renal protective effects of glutathione in the chelation therapy process of chronic cadmium poisoning using (++)-ethylenediaminetetraacetic acid, it was found that the cadmium excretion in the kidneys of the patients in the experiment significantly increased. (23.4 ± 15.81 μg/g creatinine vs. 89.23 ± 58.52 μg/g creatinine, p < 0.01). There was no difference in the protein/creatinine and β(2)-microglobulin/creatinine ratio in the urine (p > 0.05) among the groups. Furthermore, microhematuria and proteinuria did not develop over the observation period of 6 months. These results suggest that glutathione administration with EDTA might be an effective treatment modality for patients with cadmium intoxication (35). Concurrent use of mannitol (28), thiamine (29), methionine (30). Antioxidants such as DMSA can also enhance therapeutic efficacy. In response to concerns about renal tubular damage associated with EDTA therapy, some experts have proposed sauna therapy, which involves storing cadmium in sweat and excreting it during the sauna process. Although the rate of excretion is slower than that of EDTA chelation therapy, it has a significant effect in cases of chronic cadmium poisoning with renal tubular damage (31).

Symptoms of chronic cadmium exposure include osteomalacia and renal tubular phosphorus loss, which can be alleviated with the use of calcium and vitamin D supplements (9, 13). Oxygen therapy and mechanical ventilation are commonly used in patients with lung injury or pulmonary edema.

In a study, rats were poisoned with cadmium acetate for 12 weeks and then treated with an oxygen-ozone mixture by intraperitoneal injection in the last 10 days of the experiment. An oxygen-ozone mixture had a protective effect on the liver and myocardium of cadmium-poisoned rats, as evidenced by weaker destructive changes in the endoplasmic reticulum, basal cytoplasm, and lysosomes of hepatocytes, and stabilization of contractile apparatus fibers in cardiomyocytes (32). When acute kidney injury occurs, renal replacement therapy (CRRT) is usually used. Meanwhile, the case results also found that glucocorticoid therapy helps to reduce lung inflammation, inhibit fibrosis, and ameliorate acute lung injury (33). Additionally, rehabilitation with Chinese herbal medicine is also effective in cadmium poisoning. A combination of Chinese and Western medicine has been attempted, using Si-Reversal Tang (epiphyllum, dried ginger, and licorice) to restore yang and save the body in the early stages. In later stages, astragalus and poria are used to replenish qi and benefit the gallbladder, which can ameliorate shock and hepatic injury. However, there are no controlled studies to validate this evidence. Eight-duanjin also failed to reverse organic damage (17).

The outcome of cadmium poisoning varies widely. Most patients have a better prognosis when diagnosed early, immediately removed from cadmium-exposed environments, and the cadmium levels in the body are reduced. However, death from acute cadmium poisoning as a result of organ failure is common, especially in older individuals, where increased sensitivity to cadmium toxicity contributes significantly to their death (18). Follow-up ranged from a few months to 17 years. It is worth that during the 17 years follow-up, patients subsequently developed delayed pulmonary fibrosis, disproving the previous view that denied the existence of permanent damage from acute cadmium pneumonia (15). At the same time this highlights the need for ongoing management and monitoring, especially in cases where chronic cadmium poisoning leads to respiratory failure or renal failure.

Several factors influence the outcome of treatment, including the patient’s health status, the duration of exposure to cadmium, the concentration of cadmium at the time of exposure, and the promptness and accuracy of clinical intervention. While many patients respond well to appropriate treatment, those with renal involvement often have more pronounced symptoms. Case reports indicate that acute cadmium poisoning can cause necrosis of the renal cortex and degeneration of the renal tubules (8), whereas chronic exposure results in proximal tubular dysfunction (e.g., proteinuria, glycosuria, and hypophosphatemia) and may progress to chronic kidney disease over time (18). These findings underscore the need for individualized treatment plans and comprehensive long-term follow-up to optimize patient outcomes.

Based on our results, we propose several recommendations for clinicians managing patients with cadmium poisoning. In cases where the patient has not highlighted a history of cadmium exposure, prioritize biochemical tests (urine cadmium and blood cadmium tests). These tests provide the most accurate and direct assessment of cadmium concentration in the body and help to reduce the risk of misdiagnosis, particularly when respiratory symptoms could be mistaken for pneumonia. This is because the levels of cadmium in the body are the most accurate and direct criterion for determining whether cadmium poisoning is present. However, in the face of non-specific symptoms and complications in different patients, clinicians should always be aware of the possible need to use complementary diagnostic tools, such as chest X-ray or ultrasound in patients with severe respiratory symptoms, and renal ultrasound in cases where biochemical testing reveals grossly elevated urinary cadmium levels. Early and accurate diagnosis is critical to timing treatment and preventing complications.

Long-term consequences of cadmium poisoning may include lung damage and kidney damage. Early recognition and management are essential to stop the progression of the disease. Long-term follow-up, with regular imaging evaluations, is necessary to monitor recovery and address any persistent or emerging health issues. In one case report, a 4-year follow-up chest X-ray of the reported cadmium-intoxicated patient ultimately ruled out permanent pulmonary fibrosis (13). Regular follow-up should assess the effectiveness of treatments, such as reducing cadmium concentrations and monitoring for complications. Clinicians should remain vigilant for any long-term effects or sequelae related to cadmium poisoning, particularly those affecting the kidneys and lungs.

Accurate and timely diagnosis of cadmium poisoning is crucial given the potential for rapid clinical deterioration. Cadmium poisoning occurs in several occupationally exposed populations, with certain occupational groups being at an increased risk. This underscores the importance of ongoing vigilance in these high-risk groups. Early recognition of symptoms and timely management can significantly improve patient outcomes and help prevent serious complications and sequelae.

Limitations

A significant limitation of this systematic review is the small number of cases included, which reduces confidence in the broader applicability of the findings. In addition, there are notable gaps in data from the included studies, particularly concerning follow-up and long-term treatment outcomes. Several studies emphasized short-term responses and immediate treatment effects, providing limited information on the long-term prognosis of cadmium poisoning. In addition, there is considerable variation in reporting and treatment approaches, reflecting the lack of standardized protocols.

Conclusion

This systematic evaluation of case series and case reports highlights the complexity and variability of cadmium poisoning, a rare condition with poor prognosis. The presence of non-specific symptoms, which are easily mistaken for other diseases, along with multiple risk factors and a range of possible complications, makes the diagnosis, treatment, and monitoring of cadmium poisoning especially challenging.

Currently, clinical and biochemical examinations remain the main definitive approaches. Depending on the symptoms, additional tests such as renal and bone density examinations may be recommended. Reducing cadmium concentration in the body is central to treatment; however, there is still no optimal method for effectively removing cadmium ions due to significant side effects of the available chelating agents.

Prognosis varies widely among patients. While many achieve good outcomes, some develop lasting complications or sequelae, underscoring the need for individualized treatment plans and rigorous follow-up care.

Future research should focus on large-scale, multicenter clinical trials to establish specific diagnostic criteria and evidence-based treatment guidelines for cadmium poisoning. This will help improve early identification, management, and long-term care for affected patients.

Cadmium poisoning represents a critical occupational and public health challenge that necessitates comprehensive preventive strategies. Policy makers and regulatory authorities should prioritize reducing cadmium use through safer alternatives, enforcing workplace safety standards such as adequate ventilation and provision of protective equipment, and implementing routine biomonitoring for high-risk occupational groups. Furthermore, strengthening legislation and regulatory oversight of cadmium-related industries, together with improving diagnostic and therapeutic capacity within medical and rehabilitation institutions, is essential to mitigate long-term health consequences and reduce disease burden.

Data availability statement

The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.

Author contributions

ZS: Writing – original draft. MW: Writing – original draft. OM: Writing – review & editing. CJ: Writing – original draft, Writing – review & editing.

Funding

The author(s) declare that financial support was received for the research and/or publication of this article. This study was supported by National Natural Science foundation of China (No. 82474677).

Acknowledgments

We thank all the participants and clinical researchers involved in the publications cited in this study. All authors listed meet the authorship criteria according to the latest guidelines of the International Committee of Medical Journal Editors, and that all authors are in agreement with the manuscript.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declare that no Gen AI was used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Footnotes

1. ^Available online at: https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fjbi.global%2Fsites%2Fdefault%2Ffiles%2F2021-10%2FChecklist_for_Case_Reports.docx&wdOrigin=BROWSELINK

References

1. Kazantzis, G, and Armstrong, BG. A mortality study of cadmium workers in the United Kingdom. Scand J Work Environ Health. (1982) 8:157–60.

Google Scholar

2. Scott, R, Paterson, PJ, Mills, EA, McKirdy, A, Fell, GS, Ottoway, JM, et al. Clinical and biochemical abnormalities in coppersmiths exposed to cadmium. Lancet. (1976) 2:396–8.

Google Scholar

3. Goyer, RA, Tsuchiya, K, Leonard, DL, and Kahyo, H. Aminoaciduria in Japanese workers in the lead and cadmium industries. Am J Clin Pathol. (1972) 57:635–42.

Google Scholar

4. Yapici, G, Can, G, Kiziler, AR, Aydemir, B, Timur, IH, and Kaypmaz, A. Lead and cadmium exposure in children living around a coal-mining area in Yatağan, Turkey. Toxicol Ind Health. (2006) 22:357–62. doi: 10.1177/0748233706071740

PubMed Abstract | Crossref Full Text | Google Scholar

5. Yates, DH, and Goldman, KP. Acute cadmium poisoning in a foreman plater welder. Br J Ind Med. (1990) 47:429–31.

Google Scholar

6. Sharma, G, Nath, R, and Gill, KD. Effect of ethanol on cadmium-induced lipid peroxidation and antioxidant enzymes in rat liver. Biochem Pharmacol. (1991) 42:S9–S16.

Google Scholar

7. Gallagher, CM, Chen, JJ, and Kovach, JS. The relationship between body iron stores and blood and urine cadmium concentrations in US never-smoking, non pregnant women aged 20-49 years. Environ Res. (2011) 111:702–7. doi: 10.1016/j.envres.2011.03.007

PubMed Abstract | Crossref Full Text | Google Scholar

8. Taylor, A, Jackson, MA, Patil, D, Burston, J, and Lee, HA. Poisoning with cadmium fumes after smelting lead. Br Med J (Clin Res Ed). (1984) 288:1270–1.

Google Scholar

9. Roy, A, Saha, T, Sahoo, J, and Das, A. Hypophosphatemic osteomalacia due to cadmium toxicity in silverware industry: a curious case of aches and pains. J Family Med Prim Care. (2024) 13:2516–9. doi: 10.4103/jfmpc.jfmpc_1836_23

PubMed Abstract | Crossref Full Text | Google Scholar

10. Nordberg, GF. Chelating agents and cadmium toxicity: problems and prospects. Environ Health Perspect. (1984) 54:213–8.

Google Scholar

11. Ando, Y, Shibata, E, Tsuchiyama, F, and Sakai, S. Elevated urinary cadmium concentrations in a patient with acute cadmium pneumonitis. Scand J Work Environ Health. (1996) 22:150–3.

Google Scholar

12. Page, MJ, McKenzie, JE, Bossuyt, PM, Boutron, I, Hoffmann, TC, Mulrow, CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. (2021) 372:n71. doi: 10.1136/bmj.n71

Crossref Full Text | Google Scholar

13. Townshend, RH. A case of acute cadmium pneumonitis: lung function tests during a four-year follow-up. Br J Ind Med. (1968) 25:68–71.

Google Scholar

14. Seidal, K, Jörgensen, N, Elinder, CG, Sjögren, B, and Vahter, M. Fatal cadmium-induced pneumonitis. Scand J Work Environ Health. (1993) 19:429–31.

Google Scholar

15. Townshend, RH. Acute cadmium pneumonitis: a 17-year follow-up. Br J Ind Med. (1982) 39:411–2.

Google Scholar

16. Blejer, HP, Caplan, PE, and Alcocer, AE. Acute cadmium fume poisoning in welders--a fatal and a nonfatal case in California. Calif Med. (1966) 105:290–6.

Google Scholar

17. Zhou, YS, Zeng, RX, Zhang, MZ, and Guo, LH. Treatment of an acute severe cadmium poisoning patient combined with multiple organ dysfunction syndromes by integrated Chinese and Western medicines: a case report. Chin J Integr Med. (2020) 26:853–6. doi: 10.1007/s11655-020-3089-4

PubMed Abstract | Crossref Full Text | Google Scholar

18. Wittman, R, and Hu, H. Cadmium exposure and nephropathy in a 28-year-old female metals worker. Environ Health Perspect. (2002) 110:1261–6. doi: 10.1289/ehp.021101261

PubMed Abstract | Crossref Full Text | Google Scholar

19. Grasmick, C, Huel, G, Moreau, T, and Sarmini, H. The combined effect of tobacco and alcohol consumption on the level of lead and cadmium in blood. Sci Total Environ. (1985) 41:207–17.

Google Scholar

20. Wanigasuriya, KP, Peiris-John, RJ, and Wickremasinghe, R. Chronic kidney disease of unknown aetiology in Sri Lanka: is cadmium a likely cause? BMC Nephrol. (2011) 12:32. doi: 10.1186/1471-2369-12-32

PubMed Abstract | Crossref Full Text | Google Scholar

21. Akesson, A, Stål, P, and Vahter, M. Phlebotomy increases cadmium uptake in hemochromatosis. Environ Health Perspect. (2000) 108:289–91. doi: 10.1289/ehp.108-1638026

PubMed Abstract | Crossref Full Text | Google Scholar

22. Brzóska, MM, Galażyn-Sidorczuk, M, and Dzwilewska, I. Ethanol consumption modifies the body turnover of cadmium: a study in a rat model of human exposure. J Appl Toxicol. (2013) 33:784–98. doi: 10.1002/jat.2734

PubMed Abstract | Crossref Full Text | Google Scholar

23. Beton, DC, Andrews, GS, Davies, HJ, Howells, L, and Smith, GF. Acute cadmium fume poisoning. Five cases with one death from renal necrosis. Br J Ind Med. (1966) 23:292–301.

Google Scholar

24. Jones, MM, and Cherian, MG. The search for chelate antagonists for chronic cadmium intoxication. Toxicology. (1990) 62:1–25.

Google Scholar

25. Engström, B. Effects of chelating agents on oral uptake and renal deposition and excretion of cadmium. Environ Health Perspect. (1984) 54:219–32.

Google Scholar

26. Kennedy, A. Hypocalcaemia in experimental cadmium poisoning. Br J Ind Med. (1966) 23:313–7.

Google Scholar

27. Born, T, Kontoghiorghe, CN, Spyrou, A, Kolnagou, A, and Kontoghiorghes, GJ. EDTA chelation reappraisal following new clinical trials and regular use in millions of patients: review of preliminary findings and risk/benefit assessment. Toxicol Mech Methods. (2013) 23:11–7. doi: 10.3109/15376516.2012.730562

PubMed Abstract | Crossref Full Text | Google Scholar

28. Tandon, SK, Singh, S, Prasad, S, et al. Reversal of cadmium induced oxidative stress by chelating agent, antioxidant or their combination in rat. Toxicol Lett. (2003) 145:211–7. doi: 10.1016/S0378-4274(03)00265-0

PubMed Abstract | Crossref Full Text | Google Scholar

29. Tandon, SK, and Prasad, S. Effect of thiamine on the cadmium chelating capacity of thiol compounds. Hum Exp Toxicol. (2000) 19:523–8. doi: 10.1191/096032700668935303

PubMed Abstract | Crossref Full Text | Google Scholar

30. Tandon, SK, Singh, S, and Prasad, S. Influence of methionine administration during chelation of cadmium by CaNa3DTPA and DMPS in the rat. Environ Toxicol Pharmacol. (1997) 3:159–65.

Google Scholar

31. Genuis, SJ, Birkholz, D, Rodushkin, I, and Beesoon, S. Blood, urine, and sweat (BUS) study: monitoring and elimination of bioaccumulated toxic elements. Arch Environ Contam Toxicol. (2011) 61:344–57. doi: 10.1007/s00244-010-9611-5

PubMed Abstract | Crossref Full Text | Google Scholar

32. Kuryszko, J, Madej, JA, and Madej, P. Ultrastructural studies on organs of cadmium-poisoned rats treated with oxygen-ozone mixture. Arch Vet Pol. (1995) 35:109–15.

Google Scholar

33. Cepkova, M, and Matthay, MA. Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome. J Intensive Care Med. (2006) 21:119–43. doi: 10.1177/0885066606287045

PubMed Abstract | Crossref Full Text | Google Scholar

34. Blainey, JD, Adams, RG, Brewer, DB, and Harvey, TC. Cadmium-induced osteomalacia. Br J Ind Med. (1980) 37:278–84.

Google Scholar

35. Gil, HW, Kang, EJ, Lee, KH, Yang, JO, Lee, EY, and Hong, SY. Effect of glutathione on the cadmium chelation of EDTA in a patient with cadmium intoxication. Hum Exp Toxicol. (2011) 30:79–83. doi: 10.1177/0960327110369818

PubMed Abstract | Crossref Full Text | Google Scholar